2016 ASH Meeting on Hematologic Malignancies

Description
Access recorded “How I Treat” presentations and topic-based panel discussions from the 2016 ASH Meeting on Hematologic Malignancies. Hear the top experts in the field discuss the latest developments in clinical care, showcase their evidence-based treatment approaches, and provide answers to challenging patient care questions.
Pricing
Member Type | Price |
---|---|
List Price | $275.00 |
Active, International, Emeritus, and Honorary Members | $100.00 |
Associate, International Associate, Student, and Resident Members | $75.00 |
Sessions
Education Program
- Welcome and Opening Remarks (Day 1)
- How I Treat Hodgkin Lymphoma
- How I Treat Follicular Lymphoma
- How I Treat Mantle Cell Lymphoma
- Lymphoma Panel Discussion I
- How I Treat Low Grade MDS
- How I Treat High Grade MDS
- MDS Panel Discussion
- How I Treat Myelofibrosis Patients Who Have “Failed” Ruxolitinib
- How I Treat High-Risk Patients with Essential Thrombocythemia or Polycythemia Vera
- How I Treat MPN or CML: Who and When Am I Transplanting?
- MPN Panel Discussion
- How I Treat CLL
- How I Treat CLL: High-Risk Genetics
- CLL Panel Discussion
- Welcome and Opening Remarks
- How I Treat Hypocellular MDS
- How I Treat Relapsed AML: Do Molecular Genetics Help?
- MDS/AML Panel Discussion
- How I Treat ALL in First Complete Remission: Role of MRD and Molecular Genetics in Treatment Decisions
- How I Treat ALL in Older Adults: Ph+ and Ph- ALL
- ALL Panel Discussion
- How I Treat Diffuse Large B-Cell and Mediastinal Large Cell Lymphomas
- How I Treat Highly Aggressive Lymphomas: Burkitt, Double-Hit, B-Cell, and Unclassifiable with Features Intermediate between DLBCL and Burkitt Lymphoma
- Lymphoma Panel Discussion II
- How I Treat Myeloma Using Genomic Analysis
- How I Treat Newly Diagnosed Multiple Myeloma
- How I Treat Relapsed/Refractory Myeloma Including Novel Agents
- Myeloma Panel Discussion
- Closing Remarks and Adjournment